These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2848706)
1. The behaviorally active peptide ACTH 4-10: measurement in plasma and pharmacokinetics in man. Bickel U; Born J; Fehm HL; Distler M; Voigt KH Eur J Clin Pharmacol; 1988; 35(4):371-7. PubMed ID: 2848706 [TBL] [Abstract][Full Text] [Related]
2. Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue. Wellhöner P; Hörster R; Jacobs F; Sayk F; Lehnert H; Dodt C Int J Obes (Lond); 2012 May; 36(5):703-8. PubMed ID: 21629206 [TBL] [Abstract][Full Text] [Related]
3. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration. DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233 [TBL] [Abstract][Full Text] [Related]
4. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans. Smolnik R; Mölle M; Fehm HL; Born J Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094 [TBL] [Abstract][Full Text] [Related]
5. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280 [TBL] [Abstract][Full Text] [Related]
6. Brain transfer of a new neuromodulating ACTH analog, ebiratide, in rats. Shimura T; Tabata S; Hayashi S Peptides; 1991; 12(3):509-12. PubMed ID: 1681522 [TBL] [Abstract][Full Text] [Related]
7. Proteolysis of His-Phe-Arg-Trp-Pro-Gly-Pro in the blood and brain of rats in vivo. Shevchenko KV; Nagaev IY; Babakov VN; Andreeva LA; Shevchenko VP; Radilov AS; Myasoedov NF Dokl Biochem Biophys; 2015; 464():301-4. PubMed ID: 26518553 [TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Kellner M; Wiedemann K; Holsboer F Life Sci; 1992; 50(24):1835-42. PubMed ID: 1317939 [TBL] [Abstract][Full Text] [Related]
9. Sniffing neuropeptides: a transnasal approach to the human brain. Born J; Lange T; Kern W; McGregor GP; Bickel U; Fehm HL Nat Neurosci; 2002 Jun; 5(6):514-6. PubMed ID: 11992114 [No Abstract] [Full Text] [Related]
10. Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics. Schipper NG; Verhoef JC; De Lannoy LM; Romeijn SG; Brakkee JH; Wiegant VM; Gispen WH; Merkus FW Br J Pharmacol; 1993 Dec; 110(4):1335-40. PubMed ID: 8306072 [TBL] [Abstract][Full Text] [Related]
11. Entry of the synthetic ACTH(4-10) analogue into the rat brain following intravenous injection. Potaman VN; Antonova LV; Dubynin VA; Zaitzev DA; Kamensky AA; Myasoedov NF; Nezavibatko VN Neurosci Lett; 1991 Jun; 127(1):133-6. PubMed ID: 1652713 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ketanserin in man. Reimann IW; Okonkwo PO; Klotz U Eur J Clin Pharmacol; 1983; 25(1):73-6. PubMed ID: 6617728 [TBL] [Abstract][Full Text] [Related]
15. Intravenous application of ovine and human corticotropin releasing factor (CRF): ACTH, cortisol and CRF levels. Stalla GK; Hartwimmer J; Schopohl J; von Werder K; Müller OA Neuroendocrinology; 1986; 42(1):1-5. PubMed ID: 3001563 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056 [TBL] [Abstract][Full Text] [Related]
17. The clearance of ACTH from the plasma of adult and fetal sheep. Jones CT; Luther E; Ritchie JW; Worthington D Endocrinology; 1975 Jan; 96(1):231-4. PubMed ID: 162880 [TBL] [Abstract][Full Text] [Related]
18. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009 [TBL] [Abstract][Full Text] [Related]
19. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. Frohman LA; Thominet JL; Webb CB; Vance ML; Uderman H; Rivier J; Vale W; Thorner MO J Clin Invest; 1984 May; 73(5):1304-11. PubMed ID: 6425363 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the disappearance of bioactive and radioimmunoreactive ACTH from plasma in man. Besser GM; Orth DN; Nicholson WE; Byyny RL; Abe K; Woodham JP J Clin Endocrinol Metab; 1971 May; 32(5):595-603. PubMed ID: 4325282 [No Abstract] [Full Text] [Related] [Next] [New Search]